These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 22282101

  • 1. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women.
    Archer DF, Pickar JH, MacAllister DC, Warren MP.
    Menopause; 2012 Jun; 19(6):622-9. PubMed ID: 22282101
    [Abstract] [Full Text] [Related]

  • 2. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
    Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC.
    Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
    [Abstract] [Full Text] [Related]

  • 3. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 5. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE, Ackerman RT, Koltun WD, Halvorsen MB, Lambrecht LJ.
    Menopause; 2009 May; 16(1):132-40. PubMed ID: 18971794
    [Abstract] [Full Text] [Related]

  • 6. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
    Mizunuma H.
    Climacteric; 2011 Oct; 14(5):581-9. PubMed ID: 21848497
    [Abstract] [Full Text] [Related]

  • 7. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Oct; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]

  • 8. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Oct; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.
    Archer DF, Schmelter T, Schaefers M, Gerlinger C, Gude K.
    Menopause; 2014 Mar; 21(3):227-35. PubMed ID: 23963307
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG, Drosman S, Helmond FA, Stathopoulos VM.
    Menopause; 2006 Mar; 13(6):917-25. PubMed ID: 17006377
    [Abstract] [Full Text] [Related]

  • 18. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.
    Buster JE, Koltun WD, Pascual ML, Day WW, Peterson C.
    Obstet Gynecol; 2008 Jun; 111(6):1343-51. PubMed ID: 18515518
    [Abstract] [Full Text] [Related]

  • 19. A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol.
    Gass MS, Rebar RW, Cuffie-Jackson C, Cedars MI, Lobo RA, Shoupe D, Judd HL, Buyalos RP, Clisham PR.
    Maturitas; 2004 Oct 15; 49(2):140-7. PubMed ID: 15474758
    [Abstract] [Full Text] [Related]

  • 20. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S, Ylikorkala O, Arrenbrecht S.
    Int J Fertil Womens Med; 1997 Oct 15; 42 Suppl 2():376-87. PubMed ID: 9397385
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.